| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $0.85 | - | - |
| Q1'26 | $0.86 | $0.95 | +11.1% |
| Q4'25 | $0.83 | $0.69 | -16.4% |
| Q3'25 | $0.96 | $1.06 | +10.5% |
| Q2'25 | $0.68 | $0.75 | +10.7% |
| Q1'25 | $0.76 | $0.93 | +23.2% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $4.2B | - | - |
| Q1'26 | $4.1B | $5.0B | +21.5% |
| Q4'25 | $4.2B | $4.1B | -2.9% |
| Q3'25 | - | $4.5B | - |
| Q2'25 | - | $3.8B | - |
| Q1'25 | - | $4.1B | - |
Market Data
D is currently trading at $66.97, giving Dominion Energy, Inc. a market cap of 59.17B and a P/E ratio of 20.0. Today's range spans $66.88–$68.38, with shares opening at $67.17 and moving down $0.31 (0.5%) from the prior close. DailyIQ's technical score sits at 86/100 (BUY) with a news sentiment reading of 63/100.
Over the past year D has traded between $53.36 and $68.97 - the current price is +25.5% off the 52-week low and -2.9% from the high. 29 analysts cover the stock with a Hold consensus and a mean 12-month target of $67.92 (range $64.00–$73.00), implying upside of +1.4%.
The breakout geometry on D is constructive - price at $66.97 (in the upper portion of its 52-week range in $53.36–$68.97), scoring 86/100 (BUY) with bullish sentiment (63/100). (P/E: 20.0) At 59.17B in Utilities market cap, technical breakouts through prior resistance at this capitalization tier tend to be better validated than in smaller-cap peers - institutional participation means that cleared levels attract follow-through buying rather than immediate fade behavior.
What makes D's BUY setup (86/100) particularly actionable at 59.17B in Utilities capitalization is the scale-to-move ratio: large enough to feature on institutional mandates but not so large that the percentage upside is already compressed by index inertia. At $66.97 (in the upper portion of its 52-week range in $53.36–$68.97), with sentiment running bullish at 63/100, the setup rewards conviction-sized positioning more than it does speculative small bets.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).